This study is not yet accepting patients

Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care

a study on Sciatica Acute Back Pain Lower Back Pain

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
study ends around
Principal Investigator
by Jeanne Noble, MD (ucsf)
Headshot of Jeanne Noble
Jeanne Noble

Description

Summary

The goal of this clinical trial is to compare transgluteal sciatic nerve block to standard of care to treat sciatic back pain in adult patients who present to the emergency department.

The main question it aims to answer is: Is a transgluteal sciatic nerve block better than standard of care in improving pain in ER patients with sciatic back pain?

If there is a comparison group: Researchers will compare patients who receive transgluteal sciatic nerve blocks to patients who receive standard of care to see if pain scores improve in ER patients with sciatic back pain.

Participants will be randomized into the transgluteal sciatic nerve block group or the control group (standard of care). Participants will be asked to answer questions about their pain and will be asked to walk a timed short distance.

Official Title

Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care for Emergency Department Patients With Low Back Pain and Sciatic Radiculopathy: A Randomized Controlled Trial

Keywords

Sciatica Acute, sciatica, sciatic back pain, lumbar radiculopathy, sciatic radiculopathy, Radiculopathy, Nerve Block, Ropivacaine, nerve block with ropivacaine, Transgluteal sciatic nerve block

Eligibility

You can join if…

Open to people ages 18 years and up

  • Adults aged 18 years and older
  • Presentation to ED with:
  • Acute or acute-on-chronic pain consistent with sciatica, defined as unilateral lumbosacral radicular pain radiating from the lower back or gluteal region to the posterior leg, may extend distal to the knee.
  • Pain score ≥ 5/10 on Numeric Rating Scale (NRS)

You CAN'T join if...

  • Known allergy to study medications (e.g., local anesthetics)
  • Coagulopathy or current anticoagulation therapy
  • Suspected or confirmed spinal infection, or tumor
  • Neurological deficits (bowel or bladder dysfunction, leg weakness)
  • Inability to provide informed consent

Location

  • University of California, San Francisco
    San Francisco California 94107 United States

Lead Scientist at University of California Health

  • Jeanne Noble, MD (ucsf)
    Associate Professor, Emergency Medicine, School of Medicine. Authored (or co-authored) 12 research publications

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT07397117
Study Type
Interventional
Participants
Expecting 100 study participants
Last Updated